Strength Training Hormonal Hypothesis: Do Acute Hormones Drive Growth?

For decades, the prevailing rationale for high-repetition, short-rest resistance training was its ability to maximize acute post-exercise elevations in testosterone, growth hormone (GH), and insulin-like growth factor-1 (IGF-1) — and the assumption that those hormonal spikes were the primary driver of muscle hypertrophy. Bodybuilding culture and early exercise science textbooks both cited this "hormonal hypothesis" as foundational justification for pump-inducing, lactic acid-generating training protocols. But a landmark series of RCTs by West et al. (2010, 2012) and Schoenfeld (2013) has substantially undermined this position: the magnitude of acute hormonal elevations from exercise does not appear to predict hypertrophic gains across training studies.

This research review evaluates the evidence for and against the hormonal hypothesis, examines what post-exercise testosterone and GH spikes actually represent physiologically, and identifies the local cellular mechanisms that modern sports science considers more important drivers of muscle protein synthesis.

The Hormonal Hypothesis Defined

The hormonal hypothesis, as articulated by Kraemer and Ratamess (2005), holds that acute post-exercise elevations in anabolic hormones — principally testosterone, GH, and IGF-1 — interact with androgen and GH receptors in muscle tissue, stimulating muscle protein synthesis and net protein accretion. Programs designed to maximize metabolic stress (high reps, short rest, large muscle mass involvement) were claimed to optimize this hormonal environment for hypertrophy.

The hypothesis was supported by several lines of observational evidence: (1) resistance training does acutely elevate testosterone and GH in a dose-dependent manner; (2) pharmacological supraphysiological testosterone administration (exogenous steroids) unambiguously produces hypertrophy; (3) conditions of hypogonadism (very low testosterone) impair muscle protein synthesis. The leap — that normal exercise-induced acute elevations in already-physiological testosterone cause meaningful downstream hypertrophy — is where the evidence becomes problematic.

Key Evidence Challenging the Hypothesis

The most influential challenge came from West et al. (2010), who designed an elegant split-body protocol: subjects trained one arm in isolation (producing minimal systemic hormonal response) and performed high-volume leg training immediately after (producing maximal systemic hormonal elevation). Hypertrophy in the arm was identical whether measured on days with high post-exercise hormonal response (when legs were trained first) or low hormonal response (arm-only days). The acute hormonal environment made no statistically significant difference to local muscle protein synthesis.

Schoenfeld (2013) reviewed 16 RCTs comparing high-volume/short-rest protocols (which maximize hormonal response) against lower-volume/longer-rest protocols (which minimize it) and found that when total volume load was equated, hypertrophic outcomes were not significantly different. The hormonal elevation was an epiphenomenon — a marker of training stress — rather than a causal driver.

Perhaps most compelling: post-menopausal women and men over 60 — both groups with substantially blunted post-exercise testosterone and GH responses — demonstrate muscle hypertrophy from resistance training that is proportionate to that of younger individuals when training volume and intensity are matched (Mitchell et al., 2013).

Post-Exercise Testosterone: What the Numbers Mean

A typical high-volume resistance training session (5 × 10 at 70% 1RM, large muscle groups, 60-second rest) produces a post-exercise testosterone elevation of approximately 15–30% above baseline in trained men — returning to baseline within 15–30 minutes. To contextualize: this elevation represents a shift from roughly 18 nmol/L to 21–24 nmol/L. The physiological significance of a 30-minute elevation of this magnitude, relative to the 24-hour receptor engagement required for transcriptional changes in protein synthesis genes, is highly debatable.

The key distinction: pharmacological supraphysiological elevations unambiguously drive hypertrophy. Normal exercise-induced fluctuations within the physiological range appear to be insufficient to meaningfully alter the rate or extent of muscle protein synthesis in the 24-hour post-exercise window.

Growth Hormone and Hypertrophy: The Real Relationship

Post-exercise GH elevation is more dramatic than testosterone — a high-volume lower-body session can elevate GH by 200–400% above baseline. However, the mechanistic link from this acute spike to skeletal muscle hypertrophy is indirect at best. GH's primary anabolic actions on muscle are mediated through IGF-1, which must be locally synthesized in muscle tissue (mechano-growth factor, MGF) or produced hepatically (circulating IGF-1). The short-duration acute GH spike does not appear sufficient to drive meaningful hepatic IGF-1 upregulation, and the local MGF response is determined by mechanical tension and muscle damage — not by systemic GH levels.

The clearest evidence: individuals with GH deficiency (treated with recombinant GH to restore physiological levels) gain muscle mass — but individuals administering supraphysiological GH in the absence of resistance training gain predominantly fluid retention and connective tissue, not contractile muscle (Rennie, 2003). This dissociation implies that GH's role in resistance training-induced hypertrophy is permissive rather than causative.

Local Mechanisms: The More Likely Drivers

If systemic acute hormones are not the primary drivers, current consensus in molecular exercise physiology points to three local mechanisms as the more likely candidates for resistance training-induced hypertrophy:

1. Mechanical tension: Activation of the mTORC1 signaling pathway by sarcolemmal mechanosensors (integrins, titin, the Piezo1 channel) in response to high-force muscle contraction. mTORC1 activation drives protein synthesis at the ribosomal level — a process that begins within 30 minutes of exercise and persists for 24–48 hours (Philp et al., 2011).
2. Metabolic stress: Cell swelling, accumulation of metabolites (lactate, H+, Pi), and reactive oxygen species (ROS) from glycolytic exercise appear to contribute to hypertrophic signaling through pathways that are partially independent of mTORC1. This may explain why pump-inducing, short-rest training produces hypertrophy comparable to high-tension, low-metabolic-stress training.
3. Muscle damage: Eccentric-induced sarcomere disruption triggers an inflammatory repair cascade that stimulates satellite cell proliferation and myonuclear accretion — contributing primarily to long-term hypertrophic capacity rather than acute MPS rates.

Practical Training Implications

The collapse of the hormonal hypothesis carries three important practical consequences for how athletes and coaches should design hypertrophy training:

• Rest periods need not be minimized for hypertrophy: If the goal of short rest was to maximize the hormonal spike, and the hormonal spike is irrelevant, there is no mechanistic reason to force 60-second rest periods. Schoenfeld et al. (2016) confirmed in an RCT that 3-minute rest intervals produced equal or superior hypertrophy to 1-minute rest intervals — likely because they preserved volume load and mechanical tension quality across sets.
• Total volume load matters more than hormone-inducing variables: Sets × reps × load is the primary driver of mechanical tension accumulation. Optimizing weekly volume (10–20 sets per muscle group per week) is more important than manipulating rest periods, supersets, or other tactics historically justified by hormonal optimization.
• High-rep, short-rest training is not superior for hypertrophy — but it is not inferior either: It works, but through metabolic stress and accumulated mechanical tension across high reps — not through hormonal mediation. Programs can be designed around athlete preference and exercise tolerance rather than hormonal optimization dogma.

What Velocity Data Tells Us About Hormonal Load

An interesting byproduct of the hormonal hypothesis discussion is the question of how to gauge cumulative training stress — the original motivation for tracking hormonal responses. If we cannot reliably use hormonal assays in field settings, what objective indicators of accumulated training stress are available to coaches?

Mean concentric velocity and countermovement jump height have emerged as the most practical field markers. CMJ height correlates with neuromuscular readiness (r ≈ 0.68–0.79 with testosterone-to-cortisol ratio as a broader stress index in trained athletes; Claudino et al., 2017). A declining CMJ trend over 7–10 days is a better predictor of meaningful fatigue accumulation than any single post-exercise hormone measurement.

For velocity-based training: tracking the velocity-load profile slope over a mesocycle captures the net outcome of all training stresses — hormonal, neural, structural — in a single objective metric. A rightward shift (same velocity at a higher load) indicates positive adaptation regardless of the underlying hormonal mechanisms. A leftward shift indicates cumulative fatigue and warrants a deload, again regardless of mechanism. This outcome-focused approach makes the hormonal debate practically irrelevant for day-to-day training management.